Royalty Pharma Income Statement (2019-2025) | RPRX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
573.03M554.96M585.77M575.70M562.05M535.96M573.46M565.75M683.97M538.20M536.31M596.07M567.98M537.27M564.69M593.64M568.25M578.66M609.29M621.99M
Operating items
Amortization - Intangibles (Quarter)
5.67M5.73M5.80M5.80M5.67M
Research & Development (Quarter)
2.60M3.10M90.50M103.80M100.50M0.60M25.50M50.50M0.50M0.50M50.50M0.50M0.50M0.50M0.50M0.50M50.50M250.00M50.50M50.50M
Selling, General & Administrative (Quarter)
43.16M44.92M48.59M46.16M51.54M51.84M50.69M73.23M85.69M47.63M57.23M59.19M57.65M54.71M56.72M67.59M110.70M179.77M118.73M164.27M
Other Operating Expenses (Quarter)
297.97M-238.01M143.63M272.32M190.29M105.72M305.06M924.67M118.80M241.23M277.14M-76.51M583.60M212.43M-227.60M164.04M-127.14M-60.90M12.90M18.84M
Operating Expenses (Quarter)
343.73M-189.99M282.72M422.28M342.33M158.16M381.25M1,048.40M205.00M289.36M384.87M-16.83M641.75M267.64M-170.38M232.13M34.06M368.87M182.13M233.61M
Operating Income (Quarter)
229.30M744.95M303.05M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M388.38M
EBIT (Quarter)
229.30M744.95M303.05M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M388.38M
Non-operating items
Non Operating Investment Income (Quarter)
-2.56M-1.91M-16.97M-0.10M71.81M25.79M-0.98M7.09M-0.70M-8.68M3.00M-9.00M-1.00M-2.00M4.00M-1.00M
Interest & Investment Income (Quarter)
16.60M14.04M12.26M10.64M9.53M10.92M14.03M43.85M16.70M25.65M23.44M6.50M7.42M13.38M17.51M9.04M11.29M8.33M6.90M7.07M
Other Non Operating Income (Quarter)
0.04M-0.11M-0.79M-4.82M-1.76M-1.03M-10.80M-1.17M-2.81M1.09M-1.71M-18.31M-3.69M6.00M-1.65M-2.19M-3.06M-1.54M-1.57M-8.17M
Non Operating Income (Quarter)
0.04M-0.11M-81.26M-4.82M-1.76M113.81M-10.80M-1.17M-2.81M102.50M-29.36M-124.98M-3.69M6.00M-1.65M-2.19M-3.06M-1.54M17.05M-229.15M
Net income details
EBT (Quarter)
158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M355.91M
Profit After Tax (Quarter)
158.98M806.75M221.80M53.67M51.76M304.50M220.41M-797.26M340.75M227.62M72.11M494.34M-4.27M194.38M543.99M680.04M433.43M30.18M444.21M214.21M
Equity Income (Quarter)
-1.92M55.49M-19.29M-1.51M0.40M0.74M-3.25M-31.32M34.61M41.27M-5.22M55.15M77.73M-47.12M50.85M31.65M6.44M2.69M15.95M86.66M
Income from Non-Controlling Interests (Quarter)
89.86M365.98M119.87M45.77M76.32M187.09M77.76M-153.95M168.33M123.71M49.96M223.25M-9.05M92.37M262.37M126.14M195.08M60.46M155.99M141.71M
Income from Continuing Operations (Quarter)
158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M355.91M
Consolidated Net Income (Quarter)
158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M355.91M
Income towards Parent Company (Quarter)
158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M355.91M
Net Income towards Common Stockholders (Quarter)
158.98M806.75M221.80M53.67M128.08M491.60M220.41M-610.03M509.09M351.34M122.08M717.59M-4.27M194.38M806.36M334.35M433.43M90.64M444.21M355.91M
Additional items
EPS (Basic) (Quarter)
0.181.080.240.130.120.700.32-1.040.760.510.161.110.010.231.220.470.550.070.670.50
EPS (Weighted Average and Diluted) (Quarter)
0.181.080.240.130.120.700.32-1.040.760.500.161.100.010.231.210.470.550.070.670.50
Shares Outstanding (Weighted Average) (Quarter)
389.76M409.34M428.23M414.79M433.96M435.14M439.29M437.96M445.61M448.02M448.44M447.60M448.62M449.82M449.08M448.19M435.48M423.51M431.89M429.80M
Shares Outstanding (Diluted Average) (Quarter)
607.15M607.16M607.15M414.80M607.20M607.21M607.21M437.97M607.25M605.86M601.14M602.90M597.48M596.91M592.73M594.11M578.10M570.16M559.61M564.46M
EBITDA (Quarter)
58.75M436.73M93.60M153.42M219.72M377.79M192.21M-482.65M478.97M248.84M151.44M612.90M-73.77M269.63M735.07M361.51M534.18M209.80M427.16M388.38M
Interest Expenses (Quarter)
37.41M37.43M44.33M46.97M47.06M46.97M46.98M46.95M46.95M46.95M46.03M47.26M44.23M49.01M66.51M65.76M65.26M68.67M79.56M94.17M